These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone. Nordström AL; Farde L; Eriksson L; Halldin C Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390 [TBL] [Abstract][Full Text] [Related]
17. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study. Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105 [TBL] [Abstract][Full Text] [Related]
18. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study. Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754 [TBL] [Abstract][Full Text] [Related]
19. In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans. Cambon H; Baron JC; Boulenger JP; Loc'h C; Zarifian E; Maziere B Br J Psychiatry; 1987 Dec; 151():824-30. PubMed ID: 2901886 [TBL] [Abstract][Full Text] [Related]
20. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]